MdxHealth Company

MDxHealth is a molecular diagnostics company that develops epigenetic tests for cancer assessment and personalized treatment of patients.
Industry: Molecular
Headquarters: Irvine, California, United States
Founded Date: 2003-01-01
Employees Number: 51-100
Funding Status: IPO
Acquisitions Number: 2
Investors Number: 8
Total Funding: $92,375,489.00
Estimated Revenue: $1M to $10M
Last Funding Date: 2022-08-02
Last Funding Type: Post-IPO Debt

Visit Website
info@mdxhealth.com
http://twitter.com/MDxHealth
Register and Claim Ownership